IDF atlas 2025: Global Diabetes Prevalence and Gestational Diabetes Mellitus
Nilanjan Dam1, Abhishek Verma2, Abhimanyou Singh Jasrotia3, Garima4, Jaya Bajpai5, Nitin6, Rishabh kumar7. 1,2,3,4,5,6,7 PG Students, Department of Community Medicine, Rama Medical College Hospital and Research Centre, RMCHRC, Kanpur Submitted: 20 April 2025; Accepted: 26 April 2025; Published: 28 April 2025 Corresponding Author: Dr. Nilanjan Dam, MD Fellow, Department of Community Medicine, RMCHRC, Kanpur, U.P., India. Email: [email protected] Introduction India is one of the seven countries and territories in the IDF South-East Asia region, a pivotal area in the fight against diabetes. Currently, a staggering 589 million people around the globe have diabetes, with 107 million of them in the SEA region alone. Alarmingly, projections indicate that this number could surge to 185 million by 2050. We must address this growing health crisis with urgency and commitment. Diabetes in India (2024) In India, the total adult population is 947,373,600, and 10.5% of the age group 20 to 79 are suffering from Diabetes, with 89,826900 adult cases. Diabetes has reached pandemic levels, and India has become the diabetes capital, with 89.8 million people affected in 2024 (10.5% of the population). This number is projected to rise to 156.7 million by 2050(Figure 1). It is crucial to shift our focus towards the primordial prevention of diabetes. We need a reliable test for predicting gestational diabetes mellitus (GDM) so that timely and appropriate interventions can be initiated [1].